Kronox Lab Sciences
Kronox Lab Sciences Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Kronox Lab Sciences Limited, framed against the sector median so the premium or discount is obvious at a glance.
Kronox Lab Sciences Limited trades at a P/E of 20.54× and P/B of 4.89×.
Valuation
Profitability
Growth
Financial Health
Kronox Lab Sciences Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Kronox Lab Sciences Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Kronox Lab Sciences Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Kronox Lab Sciences Limited, switchable between annual and quarterly views, consolidated or standalone.
Kronox Lab Sciences Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹5,45,83,69,440 Cr and reported EPS of ₹7.45.
Kronox Lab Sciences segment analysis: revenue and profit mix.
Disclosed business segments at Kronox Lab Sciences with their share of revenue and profit, switchable between consolidated and standalone reporting.
Kronox Lab Sciences discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Kronox Lab Sciences Limited.
Our AI distills the core fundamental drivers supporting Kronox Lab Sciences Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Kronox Lab Sciences Limited's investment case rests on 8 positive markers and 7 flagged concerns drawn from the latest reported filings.
What you're getting.
Kronox Lab Sciences demonstrates exceptional profitability with a high Return on Capital Employed (ROCE) of 43.80% and Return on Equity (ROE) of 32.60%, significantly outperforming many industry benchmarks.
The company maintains a robust financial structure, being completely debt-free with a 0.00 debt-to-equity ratio, providing strong financial stability and flexibility for future growth initiatives.
Promoter confidence is very high, evidenced by a substantial 74.21% promoter holding, which aligns management and shareholder interests, fostering long-term strategic stability.
Kronox's P/E ratio of 21.90 is notably lower than many peers in the Specialty Chemicals sector, suggesting potential undervaluation and an attractive entry point for investors.
The company consistently delivers strong operational performance, reflected in a healthy Operating Profit Margin (OPM) of 33.10%, indicating efficient cost management and strong core business profitability.
What can break it.
A notable decline in FII holdings from 1.56% to 0.03% and DII holdings from 4.34% to 1.93% over the past year indicates a decreasing institutional investor interest in the company.
The company experienced a negative quarterly sales growth of -3.57%, suggesting a potential slowdown in revenue generation and raising concerns about short-term top-line performance.
Kronox's stock price has seen a significant correction, trading at 151.00, well below its 52-week high of 229.00, which could signal investor apprehension or market volatility.
The increasing public shareholding, rising from 19.89% to 23.84%, alongside declining institutional stakes, might suggest a shift in investor sentiment or liquidity concerns.
Kronox faces intense competition from larger, more established players in the Specialty Chemicals sector, which could impact market share and pricing power in the long run.
What would change my mind.
Trim if P/E re-rates above 27. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 22%. The operating engine is no longer compounding capital efficiently.
Kronox Lab Sciences Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Kronox Lab Sciences Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
Kronox Lab Sciences Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Kronox Lab Sciences Limited — derived from the live tape, not yesterday's close.
Kronox Lab Sciences Limited last traded at ₹147.11 with an intraday range of ₹145.65–₹149.78 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹147.11| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 157.64 | +10.53 | +7.16% |
| R3 | 153.51 | +6.40 | +4.35% |
| R2 | 151.64 | +4.53 | +3.08% |
| R1 | 149.38 | +2.27 | +1.54% |
| PIVOT | 147.51 | 0.40 | 0.27% |
| CURRENT | 147.11 | — | — |
| S1 | 136.99 | -10.12 | -6.88% |
| S2 | 141.12 | -5.99 | -4.07% |
| S3 | 143.38 | -3.73 | -2.53% |
| S4 | 145.25 | -1.86 | -1.27% |
KRONOX is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: 145.65 ~ 149.43
Trading Inside opening range
Kronox Lab Sciences Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Kronox Lab Sciences Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Kronox Lab Sciences Limited stood at 48.5% of traded volume, against a 20-day average of 55.4%.
Kronox Lab Sciences announcements: results, concalls, ratings, M&A.
Filings Kronox Lab Sciences sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Kronox Lab Sciences files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 32 documents below.
Disclosure under SEBI Takeover Regulations
Kronox Lab Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Price movement
Significant movement in price has been observed in Kronox Lab Sciences Limited. The Exchange, in order to ensure that investors have latest relevant…
Price movement
Significant movement in price has been observed in Kronox Lab Sciences Limited. The Exchange, in order to ensure that investors have latest relevant…
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Kronox Lab Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Copy of Newspaper Publication
Kronox Lab Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Kronox Lab Sciences dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Kronox Lab Sciences has declared, sequenced by announce and record date.
Kronox Lab Sciences corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Kronox Lab Sciences Limited: business, sector, key facts.
What Kronox Lab Sciences Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Kronox Lab Sciences Limited operates in the Specialty Chemicals industry under the Chemicals sector, listed as NSE: KRONOX, BSE: 544187.
Kronox Lab Sciences Limited is a chemical manufacturing and distribution company operating in India and globally. Their core business centers around the production and sale of a wide range of chemicals, catering to various industrial sectors. This includes substantial volumes of fine chemicals, inorganic chemicals, phosphates, and metallic chemicals.
A significant portion of Kronox's business involves supplying bulk reagents. These reagents are categorized based on their purity levels, encompassing ACS reagents and those classified as LR, AR, and GR grades. This signifies a focus on supplying chemicals for various applications requiring diverse purity standards, ranging from basic laboratory use to more stringent requirements for specific industries.
Beyond bulk reagents, Kronox offers a comprehensive portfolio of bulk ingredients tailored for multiple sectors. This includes key components for oral care products, pharmaceutical preparations (pharmacopoeia grade), food and nutraceutical products, personal care and cosmetic items, and veterinary pharmaceuticals and animal health products. This diversification demonstrates their capacity to serve a broad spectrum of industries with specialized chemical requirements.
Further enhancing their product range, Kronox specializes in the manufacture of specialty chemicals. This segment incorporates a diverse array of compounds, including tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and its derivatives, ultra-high-purity chemicals, and custom-synthesized chemicals formulated to meet specific customer specifications. The inclusion of anhydrous versions of certain chemicals highlights their capacity to provide specialized chemical forms suited for niche applications.
Established in 2008 and headquartered in Vadodara, India, Kronox has built a significant presence in the chemical industry through its diverse product portfolio and ability to cater to the varying needs of multiple sectors. Their focus on both bulk and specialty chemicals, coupled with their commitment to meeting stringent purity standards, solidifies their position within the Indian and international chemical markets.
Questions investors ask about Kronox Lab Sciences Limited (KRONOX).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Kronox Lab Sciences Limited (KRONOX)?
The current share price of Kronox Lab Sciences Limited (KRONOX) is ₹147.11. Today, the stock has gained by ₹0.09 (0.06%), trading in a range of ₹145.65 to ₹149.78. The stock opened at ₹145.65 with a trading volume of 38,835 shares.
02Is Kronox Lab Sciences Limited stock a good investment for long-term?
Kronox Lab Sciences Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹5,45,83,69,440 crores, P/E ratio of 20.54, ROE of 26.82%, and ROCE of 43.80%. The dividend yield stands at 0.34%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Kronox Lab Sciences Limited stock?
The 52-week high price of Kronox Lab Sciences Limited (KRONOX) is ₹207.49, while the 52-week low is ₹96. Currently trading at ₹147.11, the stock is 45.8% away from its 52-week low and 29.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Kronox Lab Sciences Limited stock at the current price?
Whether to buy Kronox Lab Sciences Limited stock at ₹147.11 depends on multiple factors. The stock is currently trading with a P/E ratio of 20.54 and P/B ratio of 4.89. Today's performance shows a gain of 0.06%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Kronox Lab Sciences Limited and when is the next dividend?
Kronox Lab Sciences Limited offers a dividend yield of 0.34%, which means for every ₹100 invested at the current price of ₹147.11, you can expect to receive approximately ₹0.34 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Kronox Lab Sciences Limited?
Kronox Lab Sciences Limited's key financial metrics include: P/E Ratio: 20.54, P/B Ratio: 4.89, ROE: 26.82%, ROCE: 43.80%, Dividend Yield: 0.34%, EPS: ₹7.45, Book Value: ₹31.64, and Debt-to-Equity: 0.01. The company's market cap stands at ₹5,45,83,69,440 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Kronox Lab Sciences Limited stock performing today in the market?
Kronox Lab Sciences Limited stock opened at ₹145.65 and is currently trading at ₹147.11, showing a gain of ₹0.09 (0.06%). The intraday high is ₹149.78 and low is ₹145.65. The trading volume stands at 38,835 shares, indicating moderate market participation today.
08What is the P/E ratio of Kronox Lab Sciences Limited and what does it indicate?
Kronox Lab Sciences Limited has a Price-to-Earnings (P/E) ratio of 20.54, which means investors are willing to pay ₹20.54 for every ₹1 of earnings. With an EPS of ₹7.45, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Kronox Lab Sciences Limited (KRONOX) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarti Industries (AARTIIND) Share PricePeer
- Aarti Surfactants (AARTISURF) Share PricePeer
- Archean Chemical Industries (ACI) Share PricePeer
- Aether Industries (AETHER) Share PricePeer
- Alkali Metals (ALKALI) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy